Now live: Pro — the full 13F research suite for serious investorsSee pricing →
APIS CAPITAL ADVISORS, LLC

Q3 2023 · 13F-HR

APIS CAPITAL ADVISORS, LLCholdings as filed

Filed 2023-11-13 · accession 0001420506-23-002027

$77.1M
Reported value
23
Positions
2023-09-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
01741R102ATIATI INC$14.2M18.5%346,000CommonSOLE
88642R109TDWTIDEWATER INC NEW$11.6M15.0%162,900CommonSOLE
H8817H100RIGTRANSOCEAN LTD$10.8M13.9%1,310,000CommonSOLE
M84116108SILCSILICOM LTD$6.4M8.31%245,600CommonSOLE
G9456A100GLNGGOLAR LNG LTD$6.4M8.24%262,000CommonSOLE
L72967109OECORION S.A.$6.1M7.94%288,000CommonSOLE
45816D10035YCORECARD CORPORATION$5.2M6.76%260,600CommonSOLE
268311107EDAPEDAP TMS S A$3.6M4.60%506,001CommonSOLE
501147102KRYSKRYSTAL BIOTECH INC$2.8M3.61%24,000CommonSOLE
366505105GTXGARRETT MOTION INC$2.2M2.86%280,000CommonSOLE
92686J106VKTXVIKING THERAPEUTICS INC$1.6M2.12%148,000CommonSOLE
98379L100XPELXPEL INC$1.0M1.34%13,400CommonSOLE
38911N206GRVYGRAVITY CO LTD$828,0001.07%12,000CommonSOLE
88675P103TYGOTIGO ENERGY INC$773,3781.00%110,325CommonSOLE
714157203PESIPERMA-FIX ENVIRONMENTAL SVCS$689,7000.89%66,000CommonSOLE
30049H102EVLVEVOLV TECHNOLOGIES HLDNGS IN$680,4000.88%140,000CommonSOLE
31447P100FENCFENNEC PHARMACEUTICALS INC$525,7000.68%70,000CommonSOLE
02290A102AMBRX BIOPHARMA INC$391,0000.51%34,000CommonSOLE
23954D109DAWNGBXDAY ONE BIOPHARMACEUTICALS I$355,8300.46%29,000CommonSOLE
232109108CUTREURCUTERA INC$301,0000.39%50,000CommonSOLE
038169207APLDAPPLIED DIGITAL CORP$287,0400.37%46,000CommonSOLE
15673X200CEPTON INC$212,8000.28%56,000CommonSOLE
871655106SYPRSYPRIS SOLUTIONS INC$202,7210.26%106,354CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.